Licensing Considerations and eCOA Vendor Collaborations

Episode 9 January 30, 2024 00:26:26
Licensing Considerations and eCOA Vendor Collaborations
LifeSci Talks
Licensing Considerations and eCOA Vendor Collaborations

Jan 30 2024 | 00:26:26

/

Show Notes

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA & Digital Implementation Team at AbbVie, to cover the intricacies of clinical trial licensing, contract variations among eCOA providers, the importance of sponsor involvement, and the challenges of validated translations. Explore the complexities that can arise in these critical aspects of clinical trials

Other Episodes

Episode 16

November 08, 2024 00:24:59
Episode Cover

Effective Rater Training: A Critical but Overlooked Part of COA Administration

In this episode of LifeSci Talks, TransPerfect Life Sciences’ Global Practice Leader Mark Wade sits down with Kelly Dumais PhD, Director of eCOA Science...

Listen

Episode 5

August 29, 2023 00:22:45
Episode Cover

The Future of Capturing Patient Data in Clinical Trials: DCTs, Site Staff Burden, and Regulation Considerations with Paul O'Donohoe

Mark Wade interviews Paul O'Donohoe, Senior Director of Product for eCOA and COA at Medidata. They delve into the challenges and opportunities of adopting...

Listen

Episode 20

July 01, 2025 00:23:33
Episode Cover

Balancing Innovation and Integrity: AI’s Place in Patient-Focused Research

Artificial intelligence is redefining what’s possible across the clinical development lifecycle, but with rapid innovation comes the need for thoughtful oversight. In this episode...

Listen